HIGHLIGHTS
- who: Xinran Lyu from the and Qianfoshan Hospital, Jinan, China Oncology Department, Qianfoshan have published the research: KLF14 targets ITGB1 to inhibit the progression of cervical cancer via the PI3K/AKT signalling pathway, in the Journal: (JOURNAL)
- what: The authors investigated whether KLF14 can inhibit the proliferation and promote the apoptosis of cervical cancer cells. The authors aimed to find more effective biomarkers for the diagnosis and treatment of cervical cancer.
- how: The results showed that tumours in the Lv-KLF14 group were smaller than those in the Lv-control group (Fig 3A . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.